Study of Binimetinib in Combination With Pembrolizumab in Advanced Non-Small Cell Lung Cancer
Clinical trial NCT03991819 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03991819
- Sponsor
- University Health Network, Toronto
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-20
- Primary completion
- 2026-08-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.